Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Albertsons Companies' second-quarter earnings for 2025 reflect a nuanced performance with both positive strides and areas of cautious optimism.</li><li>The company reported adjusted identical sales growth of 2.2%, with notable contributions from a 23% increase in digital sales and robust growth in its pharmacy segment, which includes significant share gains from competitor store closures.</li><li>Adjusted EBITDA stood at $848 million, while adjusted earnings per share came in at $0.44, consistent with company expectations.</li></ul>

Albertsons Companies' second-quarter earnings for 2025 reflect a nuanced performance with both positive strides and areas of cautious optimism.The company reported adjusted identical sales growth of 2.2%, with notable contributions from a 23% increase in digital sales and robust growth in its pharmacy segment, which includes significant share gains from competitor store closures.Adjusted EBITDA stood at $848 million, while adjusted earnings per share came in at $0.44, consistent with company expectations.

Albertsons Companies: An Insight Into Its Technology

<ul><li>Albertsons Companies recently reported its fourth quarter and fiscal year-end 2024 results, revealing mixed financial metrics and future prospects.</li><li>The company achieved an identical (ID) sales growth of 2.3%, primarily driven by a significant 18% increase in pharmacy sales and a robust 24% rise in digital sales.</li><li>Despite the top-line growth, gross margins, excluding fuel and LIFO expense, decreased by 45 basis points due to increased healthcare sales and delivery costs, offset partly by productivity gains.</li></ul>

Albertsons Companies recently reported its fourth quarter and fiscal year-end 2024 results, revealing mixed financial metrics and future prospects.The company achieved an identical (ID) sales growth of 2.3%, primarily driven by a significant 18% increase in pharmacy sales and a robust 24% rise in digital sales.Despite the top-line growth, gross margins, excluding fuel and LIFO expense, decreased by 45 basis points due to increased healthcare sales and delivery costs, offset partly by productivity gains.

Albertsons Is Expanding Profits & Winning Big with Smart Pricing & Cutting-Edge Technology!

<ul><li>Albertsons Companies' third quarter 2024 results showcase a strategically mixed performance with several growth initiatives balanced by ongoing challenges.</li><li>Despite the termination of the merger, the company continues to execute its Customers for Life strategy, focusing on digital transformation, customer loyalty, and enhancing the overall value proposition.</li><li>Financially, Albertsons reported a 2% increase in identical sales, driven notably by a 13% rise in pharmacy sales and 23% growth in digital sales.</li></ul>

Albertsons Companies' third quarter 2024 results showcase a strategically mixed performance with several growth initiatives balanced by ongoing challenges.Despite the termination of the merger, the company continues to execute its Customers for Life strategy, focusing on digital transformation, customer loyalty, and enhancing the overall value proposition.Financially, Albertsons reported a 2% increase in identical sales, driven notably by a 13% rise in pharmacy sales and 23% growth in digital sales.

Albertsons Companies: How Are They Managing Growth in Pharmacy and E-commerce Despite Solid Competition?

<ul><li>Albertsons Companies' Q1 2022 earnings report presents a combination of strategic progress and ongoing challenges in a dynamic market environment.</li><li>The company's performance in the first quarter shows notable growth in several areas, underscored by a 6.8% increase in identical sales, along with significant gains in both the digital and omnichannel segments.</li><li>Digital sales surged by 28%, reflecting Albertsons' emphasis on enhancing digital offerings and expanding its reach through initiatives like the Just for U Loyalty program.</li></ul>

Albertsons Companies' Q1 2022 earnings report presents a combination of strategic progress and ongoing challenges in a dynamic market environment.The company's performance in the first quarter shows notable growth in several areas, underscored by a 6.8% increase in identical sales, along with significant gains in both the digital and omnichannel segments.Digital sales surged by 28%, reflecting Albertsons' emphasis on enhancing digital offerings and expanding its reach through initiatives like the Just for U Loyalty program.

Albertsons Companies: Will Its Expansion of Private Label Brands Aid Margin Expansion? - Major Drivers

Expert on Japan Retail and Consumer Markets, JapanConsuming

Michael Causton

Expert on Japan Retail and Consumer Markets

Real Insight on Japanese Consumer Markets

JapanConsuming

JapanConsuming is a specialist research firm producing intelligence on Japanese retail and consumer markets. Founded in 2000, JapanConsuming has become the leading provider of insights on Japanese retailers and consumer trends to retailers, brands, government agencies and investors. As well as a highly regarded monthly report on the market, JapanConsuming produces in-depth reports on retail sectors, seminars on key trends and telephone consulting to investors on trends and retailers.

JapanConsuming was founded by Michael Causton and Roy Larke. 

Event-Driven

<ul>
<li>Recent reports suggest an MBO if firming up, with partial sale of US to ACT and even the Japan CVS business so a big value solution for all concerned.</li>
<li>Not so fast: an ACT purchase of 7-11 US looks more likely to be blocked given yesterday's ruling on the merger of grocery giants Kroger and Albertsons.</li>
<li>The valuation of the Japan business may need a correction too if the last six months of poor numbers continue – given this is because of price perception, they may.</li>
</ul>


Recent reports suggest an MBO if firming up, with partial sale of US to ACT and even the Japan CVS business so a big value solution for all concerned.
Not so fast: an ACT purchase of 7-11 US looks more likely to be blocked given yesterday's ruling on the merger of grocery giants Kroger and Albertsons.
The valuation of the Japan business may need a correction too if the last six months of poor numbers continue – given this is because of price perception, they may.


7&I (3382JP) - Spanners in the Works: FTC Blocks Another US Retail Merger and 7-11 Japan Sales Slump

United States

Albertsons Companies, Inc. retails food and drugs products. The Company distributes fruits, vegetables, canned items, medicines, and other related goods. Albertsons serves customers in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Albertsons Cos (ACI US)

Albertsons Companies: An Insight Into Its Technology

Albertsons Companies' second-quarter earnings for 2025 reflect a nuanced performance with both positive strides and areas of cautious...

Baptista Research

Albertsons Is Expanding Profits & Winning Big with Smart Pricing & Cutting-Edge Technology!

Albertsons Companies recently reported its fourth quarter and fiscal year-end 2024 results, revealing mixed financial metrics and future...

Baptista Research

Albertsons Companies: How Are They Managing Growth in Pharmacy and E-commerce Despite Solid Competition?

Albertsons Companies' third quarter 2024 results showcase a strategically mixed performance with several growth initiatives balanced by ongoing...

Baptista Research

Albertsons Companies: Will Its Expansion of Private Label Brands Aid Margin Expansion? - Major Drivers

Albertsons Companies' Q1 2022 earnings report presents a combination of strategic progress and ongoing challenges in a dynamic market...

Baptista Research

7&I (3382JP) - Spanners in the Works: FTC Blocks Another US Retail Merger and 7-11 Japan Sales Slump

Potential MBO of a firm may not be as straightforward as initially thought, with potential hurdles in the form of a blocked ACT purchase and a...

Michael Causton

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Albertsons Companies: An Insight Into Its Technology

Albertsons Companies' second-quarter earnings for 2025 reflect a nuanced performance with both positive strides and areas of cautious...

Baptista Research

Albertsons Is Expanding Profits & Winning Big with Smart Pricing & Cutting-Edge Technology!

Albertsons Companies recently reported its fourth quarter and fiscal year-end 2024 results, revealing mixed financial metrics and future...

Baptista Research

Albertsons Companies: How Are They Managing Growth in Pharmacy and E-commerce Despite Solid Competition?

Albertsons Companies' third quarter 2024 results showcase a strategically mixed performance with several growth initiatives balanced by ongoing...

Baptista Research

Albertsons Companies: Will Its Expansion of Private Label Brands Aid Margin Expansion? - Major Drivers

Albertsons Companies' Q1 2022 earnings report presents a combination of strategic progress and ongoing challenges in a dynamic market...

Baptista Research

7&I (3382JP) - Spanners in the Works: FTC Blocks Another US Retail Merger and 7-11 Japan Sales Slump

​Potential MBO of a firm may not be as straightforward as initially thought, with potential hurdles in the form of a blocked ACT purchase and a...

Michael Causton

Potential MBO of a firm may not be as straightforward as initially thought, with potential hurdles in the form of a blocked ACT purchase and a...